Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution

Prashant Kumar, Malini Mukherjee, Jacob P S Johnson, Milan Patel, Bing Huey, Donna Albertson, Karl Simin

Research output: Contribution to journalArticle

Abstract

Breast cancers that are "triple-negative" for the clinical markers ESR1, PGR, and HER2 typically belong to the Basal-like molecular subtype. Defective Rb, p53, and Brca1 pathways are each associated with triple-negative and Basal-like subtypes. Our mouse genetic studies demonstrate that the combined inactivation of Rb and p53 pathways is sufficient to suppress the physiological cell death of mammary involution. Furthermore, concomitant inactivation of all three pathways in mammary epithelium has an additive effect on tumor latency and predisposes highly penetrant, metastatic adenocarcinomas. The tumors are poorly differentiated and have histologic features that are common among human Brca1-mutated tumors, including heterogeneous morphology, metaplasia, and necrosis. Gene expression analyses demonstrate that the tumors share attributes of both Basal-like and Claudin-low signatures, two molecular subtypes encompassed by the broader, triple-negative class defined by clinical markers.

Original languageEnglish (US)
Article numbere1003027
JournalPLoS Genetics
Volume8
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

tumor
breast neoplasms
cancer
Breast Neoplasms
neoplasms
Neoplasms
inactivation
Breast
mammary involution
Biomarkers
Triple Negative Breast Neoplasms
metaplasia
Metaplasia
adenocarcinoma
additive effect
breasts
gene expression
cell death
necrosis
Adenocarcinoma

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Ecology, Evolution, Behavior and Systematics
  • Cancer Research
  • Genetics(clinical)

Cite this

Kumar, P., Mukherjee, M., Johnson, J. P. S., Patel, M., Huey, B., Albertson, D., & Simin, K. (2012). Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution. PLoS Genetics, 8(11), [e1003027]. https://doi.org/10.1371/journal.pgen.1003027

Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution. / Kumar, Prashant; Mukherjee, Malini; Johnson, Jacob P S; Patel, Milan; Huey, Bing; Albertson, Donna; Simin, Karl.

In: PLoS Genetics, Vol. 8, No. 11, e1003027, 11.2012.

Research output: Contribution to journalArticle

Kumar, P, Mukherjee, M, Johnson, JPS, Patel, M, Huey, B, Albertson, D & Simin, K 2012, 'Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution', PLoS Genetics, vol. 8, no. 11, e1003027. https://doi.org/10.1371/journal.pgen.1003027
Kumar, Prashant ; Mukherjee, Malini ; Johnson, Jacob P S ; Patel, Milan ; Huey, Bing ; Albertson, Donna ; Simin, Karl. / Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution. In: PLoS Genetics. 2012 ; Vol. 8, No. 11.
@article{4e0aa31ba5034eae86bba8d366227459,
title = "Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution",
abstract = "Breast cancers that are {"}triple-negative{"} for the clinical markers ESR1, PGR, and HER2 typically belong to the Basal-like molecular subtype. Defective Rb, p53, and Brca1 pathways are each associated with triple-negative and Basal-like subtypes. Our mouse genetic studies demonstrate that the combined inactivation of Rb and p53 pathways is sufficient to suppress the physiological cell death of mammary involution. Furthermore, concomitant inactivation of all three pathways in mammary epithelium has an additive effect on tumor latency and predisposes highly penetrant, metastatic adenocarcinomas. The tumors are poorly differentiated and have histologic features that are common among human Brca1-mutated tumors, including heterogeneous morphology, metaplasia, and necrosis. Gene expression analyses demonstrate that the tumors share attributes of both Basal-like and Claudin-low signatures, two molecular subtypes encompassed by the broader, triple-negative class defined by clinical markers.",
author = "Prashant Kumar and Malini Mukherjee and Johnson, {Jacob P S} and Milan Patel and Bing Huey and Donna Albertson and Karl Simin",
year = "2012",
month = "11",
doi = "10.1371/journal.pgen.1003027",
language = "English (US)",
volume = "8",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution

AU - Kumar, Prashant

AU - Mukherjee, Malini

AU - Johnson, Jacob P S

AU - Patel, Milan

AU - Huey, Bing

AU - Albertson, Donna

AU - Simin, Karl

PY - 2012/11

Y1 - 2012/11

N2 - Breast cancers that are "triple-negative" for the clinical markers ESR1, PGR, and HER2 typically belong to the Basal-like molecular subtype. Defective Rb, p53, and Brca1 pathways are each associated with triple-negative and Basal-like subtypes. Our mouse genetic studies demonstrate that the combined inactivation of Rb and p53 pathways is sufficient to suppress the physiological cell death of mammary involution. Furthermore, concomitant inactivation of all three pathways in mammary epithelium has an additive effect on tumor latency and predisposes highly penetrant, metastatic adenocarcinomas. The tumors are poorly differentiated and have histologic features that are common among human Brca1-mutated tumors, including heterogeneous morphology, metaplasia, and necrosis. Gene expression analyses demonstrate that the tumors share attributes of both Basal-like and Claudin-low signatures, two molecular subtypes encompassed by the broader, triple-negative class defined by clinical markers.

AB - Breast cancers that are "triple-negative" for the clinical markers ESR1, PGR, and HER2 typically belong to the Basal-like molecular subtype. Defective Rb, p53, and Brca1 pathways are each associated with triple-negative and Basal-like subtypes. Our mouse genetic studies demonstrate that the combined inactivation of Rb and p53 pathways is sufficient to suppress the physiological cell death of mammary involution. Furthermore, concomitant inactivation of all three pathways in mammary epithelium has an additive effect on tumor latency and predisposes highly penetrant, metastatic adenocarcinomas. The tumors are poorly differentiated and have histologic features that are common among human Brca1-mutated tumors, including heterogeneous morphology, metaplasia, and necrosis. Gene expression analyses demonstrate that the tumors share attributes of both Basal-like and Claudin-low signatures, two molecular subtypes encompassed by the broader, triple-negative class defined by clinical markers.

UR - http://www.scopus.com/inward/record.url?scp=84870718594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870718594&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.1003027

DO - 10.1371/journal.pgen.1003027

M3 - Article

VL - 8

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 11

M1 - e1003027

ER -